TY  - JOUR
AU  - Romero-Zerbo, Silvana Y
AU  - García-Fernández, María
AU  - Espinosa-Jiménez, Vanesa
AU  - Pozo-Morales, Macarena
AU  - Escamilla-Sánchez, Alejandro
AU  - Sánchez-Salido, Lourdes
AU  - Lara, Estrella
AU  - Cobo-Vuilleumier, Nadia
AU  - Rafacho, Alex
AU  - Olveira, Gabriel
AU  - Rojo-Martínez, Gemma
AU  - Gauthier, Benoit R
AU  - González-Mariscal, Isabel
AU  - Bermúdez-Silva, Francisco J
PY  - 2020
DO  - 10.3389/fendo.2020.00103
SN  - 1664-2392
UR  - https://hdl.handle.net/10668/26234
T2  - Frontiers in endocrinology
AB  - Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has been recently shown to modulate the immune system in different organs, but its impact in obesity-related meta-inflammation remains unstudied. We...
LA  - en
KW  - NAFLD
KW  - adipose tissue
KW  - cannabinoids
KW  - inflammation
KW  - islets of Langerhans
KW  - liver
KW  - obesity
KW  - prediabetes
KW  - Adipose Tissue
KW  - Animals
KW  - Cytoprotection
KW  - Diet, High-Fat
KW  - Disease Models, Animal
KW  - Inflammation
KW  - Liver
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Obese
KW  - Non-alcoholic Fatty Liver Disease
KW  - Obesity
KW  - Pancreas
KW  - Prediabetic State
KW  - Resorcinols
TI  - The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.
TY  - research article
VL  - 11
ER  -